Geney Bio

Scaling cell therapy from benchtop to bedside

Geney Bio is scaling cell therapy from benchtop to bedside with a low-cost, automated manufacturing platform. It enables regulatory-suitable processes to scale from development through commercial production without costly redevelopment, saving years and millions in development costs. Built on AU$8 million of UNSW R&D.

Team: Jesse Woolaston, Robert Nordon

Robert Nordon, Jesse Woolaston, Osmond Lao, Shaun Kyle, Bac Dang